Reglan Lawsuit Alleges Individual Suffered Adverse Reaction to Reglan

This Reglan lawsuit alleges that Betty Phelps developed tardive dyskinesia, a known adverse reaction to Reglan:

19. In the early 1990's, Plaintiff Betty Phelps's physicians began prescribing Reglan at a dosage of 10mg to treat epigastric problems. Plaintiff Betty Phelps continued to take Reglan/metoclopramide through early 2009.

20. The active ingredient, metoclopramide and metoclopramide HC1, is a dopamine antagonist.

21. Upon information and belief, in prescribing the Reglan/metoclopramide to Plaintiff Betty Phelps on a long-term basis, her prescribing doctor relied upon information published in the package inserts and/or the Physicians' Desk Reference (hereinafter referred to as “PDR”) or otherwise disseminated by the Reference Listed Drug Company (hereinafter referred to as “RLD”) and/or the New Drug Application Holder (hereinafter referred to as “NDA Holder”).

22. Plaintiff Betty Phelps ingested the Reglan/metoclopramide as prescribed.

23. Plaintiff Betty Phelps used the pharmaceutical drugs Reglan/metoclopramide without substantial change in the condition of the drugs between the time of design and manufacture of the drugs and the time she used the drugs as directed.

24. Plaintiff Betty Phelps' long-term ingestion of the Reglan/metoclopramide caused her injuries.

25. Plaintiff Betty Phelps was not aware of information different from or contrary to the inaccurate, misleading, materially incomplete, false and/or otherwise inadequate information disseminated in the PDR and RLD product inserts, or by the NDA Holders and/or ANDA Holders.

26. In 2007, Plaintiff Betty Phelps was exhibiting abnormal movements, which have since been linked to her use of Reglan/metoclopramide.

27. Plaintiff Betty Phselps' use of Reglan/metoclopramide, as prescribed, resulted in overexposure to the drugs, which has caused her to suffer serious, permanent and disabling injuries, including but not limited to, injuries of or associated with the central nervous and extrapyramidal motor systems, specifically Tardive Dyskinesia, a severe and often permanent disfiguring neurological movement disorder.